Can a lymph node infiltrated by malignant cells become necrotic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, Lymph Nodes Infiltrated with Cancer Can Become Necrotic

Lymph nodes infiltrated by malignant cells can and do undergo necrosis, and this is a well-documented pathologic finding across multiple cancer types. This occurs in both metastatic carcinomas and primary lymphomas 1, 2.

Pathologic Evidence

The presence of necrosis in cancer-infiltrated lymph nodes is established in pathology literature:

  • Metastatic carcinoma commonly shows necrotic changes in involved lymph nodes. In a study of colon cancer patients, 70% of those with stage III disease demonstrated necrotic changes in their metastatic lymph nodes 3.

  • Lymphomas also exhibit spontaneous extensive necrosis, occurring in approximately 25% of non-Hodgkin lymphoma cases even before treatment initiation 4. These appear as rim-enhanced masses on imaging.

  • The pathologic guidelines specifically recommend that after preoperative chemotherapy and/or radiotherapy, notation of necrotic versus non-necrotic tumor is recommended in lymph node reporting 5, confirming this is a recognized and clinically relevant finding.

Diagnostic Considerations

When necrosis is identified in a lymph node:

  • Immunohistochemistry is essential to confirm the diagnosis and distinguish metastatic carcinoma from other causes of lymph node necrosis (granulomatous inflammation, Kikuchi disease, infection) 6, 1.

  • Reticulin staining patterns differ between diseases: metastatic carcinoma shows disrupted reticular fiber networks in necrotic tissue, while lymphomas preserve the fiber network 1.

  • The necrotic tissue in metastasis exhibits heterogeneous morphology that varies between cancer types 1.

Clinical Significance

The prognostic implications of necrosis in metastatic lymph nodes vary by cancer type and may reflect tumor biology rather than simply indicating poor prognosis. In colon cancer, paradoxically, patients with necrotic changes in metastatic lymph nodes had better 5-year survival (85% vs 50%, p=0.02) 3.

Common Pitfall

Do not misinterpret necrotic metastatic carcinoma as benign granulomatous or infectious processes. Always use immunohistochemistry to confirm epithelial markers (AE1/AE3, EMA) and hormone receptors when appropriate 6.

References

1
Research

Necrosis in lymph nodes and their differential diagnoses: application of reticulin staining.

Virchows Archiv : an international journal of pathology, 2024

2
Research

Necrosis in lymph nodes.

Pathology annual, 1987

Related Questions

What is the management of a right femoral lymph node with central necrosis?
Why do cervical lymph nodes enlarge?
How should a necrotic lymph node be evaluated and managed?
How should a 12‑month‑old infant with a superficial hand wound from an electrical injury be managed?
What management is recommended for a blood pressure of 135/83 mm Hg?
Can you provide simple explanations of the pathophysiology and management for all types of headaches?
When and how can anti‑tuberculosis therapy for tuberculous lymphadenitis be discontinued?
In a 75-year-old woman attempting weight loss who reports taking over‑the‑counter pills of unknown name, with serum sodium 134 mmol/L, serum potassium 3.2 mmol/L, serum chloride 90 mmol/L, serum bicarbonate 22 mmol/L, urine potassium 15 mmol/L, and urine chloride 13 mmol/L, what is the most likely cause of her hypokalemia?
Can acute inflammation cause decreased transferrin saturation?
In a gravida 5, para 3 patient with severe hypertension (blood pressure 180/105) and proteinuria 1+, with a history of gestational hypertension in the first pregnancy, who is currently receiving methyldopa and labetalol, what is the next step in management?
How should I manage a patient with hyperkalemia (serum potassium 5.93 mEq/L) and oliguria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.